Interstitial lung disease associated with systemic sclerosis (SSc-ILD)

Respiratory Research

DOI: 10.1186/s12931-019-0980-7 Full text (OA) OpenAlex

Authors 0

Author list not loaded yet.

Cited by 6 stored of 293

Semi-quantitatively scored apical extent of disease predicts change in total lung capacity in patients with systemic sclerosis and early interstitial lung disease.
2025 Seminars in Arthritis and Rheumatism article Medicine Systemic Sclerosis and Related Diseases Open access

2

citations
Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort
2024 RMD Open article Medicine Systemic Sclerosis and Related Diseases Open access

6

citations
The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database
2024 Diagnostics article Medicine Systemic Sclerosis and Related Diseases Open access

12

citations
Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis
2022 Lara D. Veeken article Medicine Systemic Sclerosis and Related Diseases Open access

23

citations
Personalized Therapy for Mycophenolate: Consensus Report by the International Association of Therapeutic Drug Monitoring and Clinical Toxicology
2021 Therapeutic Drug Monitoring article Medicine Renal Transplantation Outcomes and Treatments Open access

208

citations
Interstitial Lung Disease in Patients With Systemic Sclerosis: Toward Personalized-Medicine-Based Prediction and Drug Screening Models of Systemic Sclerosis-Related Interstitial Lung Disease (SSc-ILD)
2020 Frontiers in Immunology article Medicine Systemic Sclerosis and Related Diseases Open access

24

citations

6 results

Interstitial lung disease associated with systemic sclerosis (SSc-ILD)

Authors 0

Cited by 6 stored of 293

References 0